|
1
|
Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, Bayer E, Haerzschel A, Gutjahr J, Postorino M, Santinelli E, Ayed A, Zaja F, Chiarenza A, Chigaev A, Sklar L, Burger J, Ferrajoli A, Shanafelt T, Wiestner A, Del Poeta G, Hartmann T, Gattei V, Zucchetto A. INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_98] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- E. Tissino
- Centro di Riferimento Oncologico, I.R.C.C.S; Clinical and Experimental Onco-Hematology Unit; Aviano Italy
| | - D. Benedetti
- Centro di Riferimento Oncologico, I.R.C.C.S; Clinical and Experimental Onco-Hematology Unit; Aviano Italy
| | - S.E. Herman
- Hematology Branch; National Heart, Lung, and Blood Institute, NIH, Bethesda; Maryland USA
| | - E. ten Hacken
- Department of Medical Oncology; Dana Farber Cancer Institute; Boston Massachusetts USA
| | - I.E. Ahn
- Hematology Branch; National Heart, Lung, and Blood Institute, NIH, Bethesda; Maryland USA
| | - K.G. Chaffee
- Department of Health Sciences Research; Mayo Clinic College of Medicine; Rochester Minnesota USA
| | - E. Bayer
- Oncologic Center, Paracelsus Medical University; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology; Salzburg Austria
| | - A. Haerzschel
- Oncologic Center, Paracelsus Medical University; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology; Salzburg Austria
| | - J.C. Gutjahr
- Oncologic Center, Paracelsus Medical University; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology; Salzburg Austria
| | - M. Postorino
- Division of Hematology; S. Eugenio Hospital and University of Tor Vergata; Rome Italy
| | - E. Santinelli
- Division of Hematology; S. Eugenio Hospital and University of Tor Vergata; Rome Italy
| | - A. Ayed
- Department of Health Sciences Research; Mayo Clinic College of Medicine; Rochester Minnesota USA
| | - F. Zaja
- Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM; Azienda Ospedaliera Universitaria S. Maria Misericordia; Udine Italy
| | - A. Chiarenza
- Division of Hematology; Ferrarotto Hospital; Catania Italy
| | - A. Chigaev
- Department of Pathology and Cancer Center; University of New Mexico; Albuquerque New Mexico USA
| | - L.A. Sklar
- Department of Pathology and Cancer Center; University of New Mexico; Albuquerque New Mexico USA
| | - J.A. Burger
- Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas USA
| | - A. Ferrajoli
- Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas USA
| | - T.D. Shanafelt
- Department of Health Sciences Research; Mayo Clinic College of Medicine; Rochester Minnesota USA
| | - A. Wiestner
- Hematology Branch; National Heart, Lung, and Blood Institute, NIH, Bethesda; Maryland USA
| | - G. Del Poeta
- Division of Hematology; S. Eugenio Hospital and University of Tor Vergata; Rome Italy
| | - T.N. Hartmann
- Oncologic Center, Paracelsus Medical University; Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology; Salzburg Austria
| | - V. Gattei
- Centro di Riferimento Oncologico, I.R.C.C.S; Clinical and Experimental Onco-Hematology Unit; Aviano Italy
| | - A. Zucchetto
- Centro di Riferimento Oncologico, I.R.C.C.S; Clinical and Experimental Onco-Hematology Unit; Aviano Italy
| |
Collapse
|